Compound: Oxeladin
SMILES: O=C(OCCOCCN(CC)CC)C(c1ccccc1)(CC)CC
InChIKey: IQADUMSPOQKAAO-UHFFFAOYSA-N
Synonyms: Oxeladin, 468-61-1, Oxeladina, Oxeladine, Oxeladinum, 2-(2-Diethylaminoethoxy)ethyl 2-ethyl-2-phenylbutyrate, 2-[2-(Diethylamino)ethoxy]ethyl 2-ethyl-2-phenylbutanoate, SNC1080T5Y, DTXSID0048343, 2-(2-(diethylamino)ethoxy)ethyl 2-ethyl-2-phenylbutanoate, RefChem:168883, DTXCID1028318, R05DB09, 207-412-1, OXELAIDIN CITRATE, 2-Ethyl-2-phenylbutyric acid 2-(2-diethylaminoethoxy)ethyl ester, Ethanol, 2-(2-(diethylamino)ethoxy)-, 2-ethyl-2-phenylbutyrate, Oxeladin (INN), Oxeladina [INN-Spanish], OXELADIN [INN], BUTYRIC ACID, 2-ETHYL-2-PHENYL-, 2-(2-(DIETHYLAMINO)ETHOXY)ETHYL ESTER, Oxeladine [INN-French], Oxeladinum [INN-Latin], Oxeladin [INN:BAN:DCF], EINECS 207-412-1, BRN 2003403, UNII-SNC1080T5Y, Oxelaidin, Pectamol (Salt/Mix), OXELADIN [MI], OXELADIN [WHO-DD], alpha,alpha-Diethylbenzeneacetic acid 2-(2-(diethylamino)ethoxy)ethyl ester, EC 207-412-1, 4-09-00-01906 (Beilstein Handbook Reference), MLS001047519, SCHEMBL405413, CHEMBL1500276, CHEBI:135424, HMS2800D17, HMS3604M03, EBC-26634, STL059065, AKOS005711563, DB04822, Benzeneacetic acid, .alpha.,.alpha.-diethyl-, 2-[2-(diethylamino)ethoxy]ethyl ester, NCGC00389219-01, NCGC00389219-02, SMR000425406, SBI-0207046.P001, NS00007663, D08310, AB00658553_05, AB00658553_06, EN300-18553895, Q4332778, BRD-K17977438-048-02-4, BRD-K17977438-048-03-2, BRD-K17977438-048-04-0, 2-[2-(Diethylamino)ethoxy]ethyl 2-ethyl-2-phenylbutanoate #, 2-(2-DIETHYLAMINOETHOXY)-ETHYL 2-ETHYL-2-PHENYLBUTYRATE, 2-(2-Diethylaminoethoxy)ethyl .alpha.,.alpha.-diethylphenylacetate, .alpha.,.alpha.-Diethylbenzeneacetic acid 2-(2-(diethylamino)ethoxy)ethyl ester, 2-Ethyl-2-phenyl-butyric acid 2-(2-diethylamino-ethoxy)-ethyl ester; compound with  3-carboxy-3-hydroxy-pentanedioic acid, Benzeneacetic acid, a,a-diethyl-, 2-[2-(diethylamino)ethoxy]ethyl ester; Butyric acid, 2-ethyl-2-phenyl-, 2-[2-(diethylamino)ethoxy]ethyl ester (6CI,7CI,8CI); Ethanol, 2-(2-diethylaminoethoxy)-, 2-ethyl-2-phenylbutyrate (6CI); 2-(2-Diethylaminoethoxy)ethy
Theoretical properties:
molecular_formula: C20H33NO3
molecular_weight: 335.5 g/mol
exact_mass: 335.24604391 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 0
hydrogen_bond_acceptor_count: 4
rotatable_bond_count: 13
heavy_atom_count: 24
topological_polar_surface_area: 38.8 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
melting_point: < 25 °C
solubility: 47.7 [ug/mL] (The mean of the results at pH 7.4)
Descriptions:
pubchem: Oxeladin is an alkylbenzene.
chembl: OXELADIN is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.
wikipedia: Oxeladin is a cough suppressant. It is a highly potent and effective drug used to treat all types of cough of various etiologies.  It is not related to opium or its derivatives, so treatment with oxeladin is free of risk of dependence or addiction. Oxeladin has none of the side effects (such as hypnosis, respiratory depression, tolerance, constipation and analgesia) which are present when common antitussives, such as codeine and its derivatives, are used. It may be used at every age, as well as in patients with heart disease, since it has a high level of safety and a great selectivity to act on the bulbar centre of cough.